Form 4: Nutanix Director-Affiliated Entity Sells Over 5.4 Million Shares at $76.81

An entity associated with Nutanix Director Max de Groen has reported the sale of 5,480,467 shares of Class A Common Stock at $76.81 per share, alongside a distribution of 125,183 shares for charitable purposes.

Summary

• Max Pieter de Groen, a Director of Nutanix, Inc., reported transactions involving Nutanix Class A Common Stock by an affiliated entity.
• On June 5, 2025, BCPE Nucleon (DE) SPV, LP, an entity where Mr. de Groen is deemed to share voting and dispositive power, sold 5,480,467 shares of Class A Common Stock at $76.81 per share. This sale was conducted under a Rule 10b5-1(c) plan.
• Following this sale, the indirect beneficial ownership through BCPE Nucleon was 5,480,468 shares.
• Additionally, on the same date, BCPE Nucleon distributed 125,183 shares of Common Stock in connection with charitable gifts.
• After this distribution, the indirect beneficial ownership through BCPE Nucleon is 5,355,285 shares.
• Mr. de Groen also directly holds 40,746 shares of Class A Common Stock, which includes 3,646 unvested restricted stock units.

Sentiment

Score: 4

Explanation: The sale of over 5.4 million shares by an entity affiliated with a director, despite being under a 10b5-1 plan, can be perceived as a negative signal by the market. However, the charitable distribution and the pre-planned nature of the sale mitigate some of the negative sentiment.

Positives

• The significant sale of 5,480,467 shares was conducted under a Rule 10b5-1(c) plan, indicating it was pre-scheduled and not necessarily based on new, non-public information.
• A portion of the shares, specifically 125,183, was distributed for charitable gifts, reflecting philanthropic activity.

Negatives

• A substantial sale of 5,480,467 shares by an entity associated with a director could be perceived negatively by the market, potentially signaling a reduction in conviction or a move to diversify holdings, despite being pre-planned.

Future Outlook

NA

Industry Context

This Form 4 filing reports an insider transaction, which is a routine disclosure for publicly traded companies. Large sales by directors or affiliated entities are closely watched by the market as they can sometimes be interpreted as signals regarding the company's future prospects or the insider's liquidity needs. However, the transaction being under a 10b5-1 plan suggests it was pre-arranged and not necessarily reactive to new information.

Related Party Transactions

• The transactions involve BCPE Nucleon (DE) SPV, LP, an entity where Director Max de Groen is deemed to share voting and dispositive power through his partnership with Bain Capital Investors, LLC. This constitutes a related party transaction as it involves an entity closely associated with a director.

Stakeholder Impact

• Shareholders may react to the large insider sale, potentially leading to short-term price volatility due to perceptions of insider confidence or liquidity needs.

Key Dates

Keywords

Nutanix, NTNX, SEC Form 4, Insider Sale, Stock Transaction, Director, Max de Groen, Bain Capital, Share Disposition, 10b5-1 Plan, Class A Common Stock